#as03 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #as03, aggregated by home.social.
-
A Phase 2 Clinical Trial to Evaluate the #Safety, Reactogenicity, and #Immunogenicity of Different Prime-Boost #Vaccination Schedules of '13 & '17 #H7N9 Inactivated #Influenza Virus Vaccines Administered with & without #AS03 Adjuvant in Healthy US Adults, Clin Infect Dis.: https://doi.org/10.1093/cid/ciae173
Administering adjuvant with 2nd H7N9 IIV dose & extending boost interval to 4 mos resulted in higher peak Ab responses. These observations can inform strategic approaches for pandemic preparedness.
-
#Immunogenicity and safety of varying dosages of a fifth-wave #influenza A/ #H7N9 inactivated #vaccine given with and without #AS03 adjuvant in healthy adults https://pubmed.ncbi.nlm.nih.gov/38105137/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAJ9poBzWGqPtjEbBDtz4ipSRRPUplmgHEyyF_Ihj&fc=None&ff=20231218031744&v=2.18.0
-
[Articles] #Efficacy of a #bivalent (D614 B.1.351) #SARS-CoV-2 recombinant protein #vaccine with #AS03 #adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00263-1/fulltext?rss=yes #research #covid19
-
[Articles] #Efficacy of a #bivalent (D614 B.1.351) #SARS-CoV-2 recombinant protein #vaccine with #AS03 #adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00263-1/fulltext?rss=yes #research #covid19
-
[Articles] #Efficacy of a #bivalent (D614 B.1.351) #SARS-CoV-2 recombinant protein #vaccine with #AS03 #adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00263-1/fulltext?rss=yes #research #covid19